Rift Valley fever virus is able to cross the human blood–brain barrier in vitro by direct infection with no deleterious effects
- Authors
- Type
- Published Article
- Journal
- Journal of Virology
- Publisher
- American Society for Microbiology
- Publication Date
- Sep 30, 2024
- Volume
- 98
- Issue
- 10
- Identifiers
- DOI: 10.1128/jvi.01267-24
- Source
- ASM Journals
- Keywords
- License
- Green
Abstract
The RVF virus (RVFV) is capable of infecting humans and inducing severe and fatal neurological disorders. Neuropathogenesis and human central nervous system (CNS) invasion mechanisms of RVFV are still unknown, with only historical studies of autopsy data from fatal human cases in the 1980s and exploration studies in rodent models. One of the gaps in understanding RVFV human pathogenesis is how RVFV is able to cross the blood–brain barrier (BBB) in order to reach the human CNS. For the first time, we show that RVFV is able to directly infect cells of the human BBB in vitro to release viral particles into the human CNS, a well-characterized neuroinvasion mechanism of pathogens. Furthermore, we demonstrate strain-dependent variability of this neuroinvasion mechanism, identifying possible viral properties that could be explored to prevent neurological disorders during RVFV outbreaks.
